Suppr超能文献

异基因骨髓移植后慢性移植物抗宿主病患者体内CD8+CD11+、CD8+CD11-和CD8+Leu7+细胞数量增加。

Increased numbers of CD8+CD11+, CD8+CD11- and CD8+Leu7+ cells in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.

作者信息

Yabe H, Yabe M, Kato S, Kimura M, Iwaki K

机构信息

Department of Paediatrics, Tokai University School of Medicine, Isehara, Japan.

出版信息

Bone Marrow Transplant. 1990 May;5(5):295-300.

PMID:1693537
Abstract

Peripheral blood lymphocytes from 25 allogeneic bone marrow transplant recipients were studied serially using flow cytometry and two colour analysis. Fourteen patients were transplanted for haematologic malignancies, eight for aplastic anaemia, two for congenital immunodeficiencies and one for Morquio's disease. All patients were alive more than 100 days post-grafting; nine patients had chronic graft-versus-host disease (GVHD). Dual labelling with monoclonal antibodies, CD4/2H4, CD4/4B4, CD8/CD11, CD8/HLA-DR and CD8/Leu 7 was used to analyse the surface phenotypes of lymphocytes. The population of CD4+2H4+ cells was decreased, and CD8+CD11+, CD8+CD11- and CD8+Leu7+ cells were markedly increased in patients with chronic GVHD. The increase of CD8+CD11+, CD8+CD11- and CD8+Leu7+ cells closely correlated with clinical signs of chronic GVHD in each patient. These results suggest that CD8+ cells may play an important role in effector and/or suppressor mechanisms of chronic GVHD and could be used as an indicator of need for and response to treatment.

摘要

对25名异基因骨髓移植受者的外周血淋巴细胞进行了连续流式细胞术和双色分析研究。14例患者因血液系统恶性肿瘤接受移植,8例因再生障碍性贫血,2例因先天性免疫缺陷,1例因黏多糖贮积症Ⅳ型。所有患者移植后存活均超过100天;9例患者发生慢性移植物抗宿主病(GVHD)。使用单克隆抗体CD4/2H4、CD4/4B4、CD8/CD11、CD8/HLA-DR和CD8/Leu 7进行双重标记,以分析淋巴细胞的表面表型。慢性GVHD患者中CD4+2H4+细胞群体减少,而CD8+CD11+、CD8+CD11-和CD8+Leu7+细胞明显增加。CD8+CD11+、CD8+CD11-和CD8+Leu7+细胞的增加与每位患者慢性GVHD的临床体征密切相关。这些结果表明,CD8+细胞可能在慢性GVHD的效应和/或抑制机制中起重要作用,并可作为治疗需求和反应的指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验